Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Integration method for enriching and detecting rare cells from biological fluid samples

A rare cell and enrichment technology, applied in the integrated field of enrichment and detection of rare cells, can solve the problems of restricting the development of circulating tumor cells and circulating endothelial cells, and achieve the effect of promoting popular application and low cost

Active Publication Date: 2014-01-15
北京莱尔生物医药科技有限公司
View PDF3 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its unavoidable high non-specific staining signal, expensive fluorescence microscope, and necessary but inconvenient working environment (such as dark room) greatly limit the detection of circulating tumor cells and circulating endothelial cells based on immunofluorescence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Integration method for enriching and detecting rare cells from biological fluid samples
  • Integration method for enriching and detecting rare cells from biological fluid samples

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Example 1. Enrichment of circulating tumor cells from the peripheral blood of breast cancer patients

[0066] 5ml of human peripheral blood was collected in blood collection tubes (BD, New Jersey, USA) containing ethylenediaminetetraacetic acid (EDTA) anticoagulant. After centrifuging the blood sample (700xg, 10 minutes), the supernatant can be aspirated using a pipette or automatic pipetting device to remove plasma proteins. The pellet obtained after centrifugation was resuspended in 30 ml of erythrocyte lysate (BD Pharmingen, California, USA) and incubated for 20 minutes. Specimens were centrifuged (700xg, 10 minutes) to separate the lysed erythrocyte fragments in the supernatant. After removing the supernatant, resuspend the pellet (ie, deposited cells) in 5 mL of phosphate buffer (pH 7.4). After adding 0.5 ml of magnetic beads coated with monoclonal antibody against leukocyte surface antigens such as CD45 (Invitrogen, California, USA) therein, incubate at room tem...

Embodiment 2

[0068] Example 2. Trichrome staining of circulating tumor cells enriched from peripheral blood of breast cancer patients

[0069] The enriched circulating tumor cells were placed on a glass slide, fixed with 2% paraformaldehyde (paraformaldehyde) prepared from phosphate buffered saline for 2 hours at room temperature, and washed 3 times with phosphate buffered saline. Cells were treated with biotin (Pierce, Illinois, USA)-labeled anti-keratin 8+18+19 monoclonal antibody (Abcam, UK, 1 μg / ml) and rhodamine (Pierce, Illinois, USA)-labeled anti-CD45 monoclonal antibody Antibody (Abcam, UK, 1 μg / ml) mixture (diluted from phosphate buffer) was incubated at room temperature for 30 minutes. After the slides were washed three times with phosphate buffered saline, they were labeled with alkaline phosphatase-labeled anti-biotin monoclonal antibody (Sigma, Missouri, USA, 1 μg / ml) and peroxidase (Pierce, Illinois, USA) Anti-rhodamine monoclonal antibody (Abcam, UK, 1 μg / ml) mixture (dilut...

Embodiment 3

[0071] Example 3. Detection of circulating tumor cells by chromosome fluorescence in situ hybridization

[0072] The enriched tumor cells were placed on slides as specimens. After the stained specimen was treated with 20 mg / ml RNase for 1 hour, the slide was rinsed with SSC buffer. The specimens were dehydrated with absolute ethanol for 10 minutes, then heated to 70°C for 5 minutes to denature. The specimen was then dehydrated with absolute ethanol for 10 minutes, and incubated overnight at 45°C for hybridization with the probe. After the specimens were washed with SSC buffer, they were observed with a fluorescence microscope. The specimen may be enriched tumor cells stained by the method in Example 2, and the purpose of performing chromosomal fluorescence in situ hybridization is to further confirm the authenticity of detecting tumor cells based on immunohistochemical trichrome staining. In order to facilitate rapid diagnosis, specimens can also be directly subjected to ch...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for detecting enriched rare cells, which is characterized in that dyeing based on the immunohistochemistry and immunofluorescence are combined, or double colors, three-colour or multicolor dyeing based on the immunohistochemistry, and the observation and the identification are performed by using fluorescence or a common optical microscope or a scanner based on microscope principles. The novel and unique enrichment and dyeing method has the advantage of low cost, and is capable of rapidly enriching and quantitatively determining the rare cells in blood with high efficiency and high specificity.

Description

[0001] This application is a divisional application of the Chinese patent application with the application number 200810097889.4 submitted on May 20, 2008, the title of the invention is "Integrated method for enriching and detecting rare cells from biological fluid samples". technical field [0002] The present invention mainly relates to an integrated method for enrichment and detection of rare cells from biological fluid samples. Background technique [0003] Since the U.S. Food and Drug Administration approved the technology of directly capturing circulating tumor cells in human peripheral blood from Immunicon / Veridex (Philadelphia, USA) in 2004, the acquisition and detection of circulating tumor cells, circulating endothelial cells, and tumor stem cells , and the important scientific research and clinical significance of certain immune cells have been widely reported (Cristofanilli et al, 2004 New Eng J. Med.351: 781; Braun and Marth, 2004 New Eng. J. Med. 351: 824 ). ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N33/533G01N21/64
Inventor 林平
Owner 北京莱尔生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com